Lantern Pharma Inc. Common Stock

LTRNNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
0.62 USD
↘ 0.01 (1.83%)AT CLOSE (03:59 PM EDT)
0.65
↗ 0.03 (4.04%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
0.65
↗ 0.03 (4.04%)
🔴Market: CLOSED

Lantern Pharma Inc. Common Stock (LTRN) is currently trading at $0.60. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (579.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Oct 26, 2026.

Open?$0.63
High?$0.66
Low?$0.60
Prev. Close?$0.64
Volume?116.1K
Avg. Volume?330.4K
VWAP?$0.63
Rel. Volume?0.35x
Bid / Ask
Bid?$0.60 × 1.1K
Ask?$0.70 × 1.5K
Spread?$0.10
Midpoint?$0.65
Valuation & Ratios
Market Cap?9.3M
Shares Out?14.9M
Float?11.4M
Float %?76.3%
P/E Ratio?N/A
P/B Ratio?-2.88
EPS?-$1.25
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyAI & Machine Learning›AI-Powered Analytics & Decision Systems
Employees
16
Market Cap
9.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.lanternpharma.com
Listed
2020-06-11
Address
1920 MCKINNEY AVENUE
DALLAS, TX 75201
Phone: 972-277-1136
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
65
Piotroski F-Score?0/9Weak
Altman Z-Score?-21.74Distress
Confidence?44%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?3.41%Low
Short Interest?388.7K
Days to Cover?1.5
Free Float11.4M
Avg Daily Volume259.3K
Settlement Date2026-10-15
Financial Health
Current Ratio?1.96Adequate
Quick Ratio?1.96Adequate
Cash Ratio?1.54Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-2.88CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
579.8%STRONG▾
ROA?
S&P
3
-216.8%WEAK▾
Cash Flow & Enterprise
FCF?$-14078189
Enterprise Value?$2.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist